ZA962461B - Low dose ridogrel formulations. - Google Patents

Low dose ridogrel formulations.

Info

Publication number
ZA962461B
ZA962461B ZA9602461A ZA962461A ZA962461B ZA 962461 B ZA962461 B ZA 962461B ZA 9602461 A ZA9602461 A ZA 9602461A ZA 962461 A ZA962461 A ZA 962461A ZA 962461 B ZA962461 B ZA 962461B
Authority
ZA
South Africa
Prior art keywords
ridogrel
formulations
low dose
dose
low
Prior art date
Application number
ZA9602461A
Inventor
Maria-Helena Joris
Josef Verlinden
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA962461B publication Critical patent/ZA962461B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
ZA9602461A 1995-03-28 1996-03-27 Low dose ridogrel formulations. ZA962461B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28

Publications (1)

Publication Number Publication Date
ZA962461B true ZA962461B (en) 1997-09-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9602461A ZA962461B (en) 1995-03-28 1996-03-27 Low dose ridogrel formulations.

Country Status (10)

Country Link
EP (1) EP0817631A2 (en)
JP (1) JPH10511097A (en)
AR (1) AR002727A1 (en)
AU (1) AU5397496A (en)
CA (1) CA2215160A1 (en)
HU (1) HUP9900309A3 (en)
IL (1) IL117670A (en)
NO (1) NO974486L (en)
WO (1) WO1996030016A2 (en)
ZA (1) ZA962461B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
SI2396081T1 (en) 2009-02-16 2017-09-29 Nogra Pharma Limited Alkylamido compounds and uses thereof
JP6301844B2 (en) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド How to treat fibrosis
BR112014026160A2 (en) 2012-04-18 2017-07-18 Nogra Pharma Ltd Methods To Treat Lactose Intolerance
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
MX2021009498A (en) 2019-02-08 2021-09-08 Nogra Pharma Ltd Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
NO974486D0 (en) 1997-09-29
HUP9900309A2 (en) 1999-05-28
WO1996030016A3 (en) 1997-01-30
AU5397496A (en) 1996-10-16
WO1996030016A2 (en) 1996-10-03
EP0817631A2 (en) 1998-01-14
CA2215160A1 (en) 1996-10-03
HUP9900309A3 (en) 1999-11-29
JPH10511097A (en) 1998-10-27
AR002727A1 (en) 1998-04-29
MX9707394A (en) 1997-11-29
IL117670A (en) 2000-02-29
IL117670A0 (en) 1996-07-23
NO974486L (en) 1997-09-29

Similar Documents

Publication Publication Date Title
ZA967745B (en) Pharmaceutical formulations.
ZA969722B (en) Pharmaceutical formulations.
EP0634459A3 (en) Formulations.
ZA962338B (en) Oral 2-methyl-thieno-benzodiazepine formulation.
GR3036937T3 (en) Pharmaceutical formulations.
AP9500733A0 (en) Pharmaceutical formulations
ZA967034B (en) Pharmaceutical compositions.
ZA966148B (en) Novel formulation.
ZA951781B (en) Pharmaceutical formulations
ZA967546B (en) Pharmaceutical formulation.
IL109362A0 (en) Improved agricultural formulations
GB9511366D0 (en) Novel formulations
ZA962461B (en) Low dose ridogrel formulations.
GB9609203D0 (en) Formulations
ZA96392B (en) Pharmaceutical formulations
GB9413542D0 (en) Pharmaceutical formulations
GB9500978D0 (en) Pharmaceutical formulations
ZA957349B (en) Pharmaceutical formulations.
ZA968757B (en) Novel formulations.
GB9509941D0 (en) Formulations
GB9510349D0 (en) Formulations
GB9508144D0 (en) Formulations
GB9508989D0 (en) Pharmaceutical formulations
GB9503752D0 (en) Pharmaceutical formulations
GB9516584D0 (en) Pharmaceutical formulations